Loading...
Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
PURPOSE: To provide minimally important difference (MID) estimates for the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 (UCLA SCTC GIT 2.0) in a longitudinal observational cohort. METHODS: We administered the UCLA SCTC GIT 2.0 to 115 patients with SSc at 2 time points 6 mont...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368014/ https://ncbi.nlm.nih.gov/pubmed/21724699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.110225 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|